Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oligosaccharides are short-chain carbohydrates composed of three to ten monosaccharide units, typically found as part of glycoconjugates like glycoproteins and glycolipids on cell surfaces [1, 7]. They play essential roles in biological processes including cell-cell recognition, the modulation of immune responses, and the stabilization of protein structures [3, 7]. In various disease states, specific oligosaccharide structures act as markers for cancer metastasis, sites for inflammatory cell recruitment, or receptors for viral and bacterial pathogens [3, 8]. Therapeutically, oligosaccharides can serve as both targets and active agents; for instance, monoclonal antibodies target tumor-associated glycans like GD2, while synthetic oligosaccharides like fondaparinux and acarbose are used to treat thrombosis and diabetes, respectively [1, 6, 9]. The immense structural diversity of these molecules, resulting from varied glycosidic linkages and branching, offers a vast but complex landscape for drug discovery and vaccine development [10, 15].
Inhibition of carbohydrate-binding proteins (lectins/selectins), induction of antibody-dependent cellular cytotoxicity (ADCC) via glycan-binding antibodies, competitive inhibition of microbial attachment, or modulation of enzyme activity through glycomimicry [1, 3, 4, 12].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oligosaccharide (OS).